PATIENT-REPORTED EXPERIENCES WITH SELF-INJECTIONS USING PREFILLED SYRINGE AND AUTOINJECTOR DEVICES IN AN OPEN-LABEL, LONG-TERM STUDY OF GALCANEZUMAB IN PATIENTS WITH MIGRAINE

被引：0
|
作者：
Stauffer, V. L. [1 ]
Sides, R. [1 ]
Lanteri-Minet, M. [2 ]
Kielbasa, W. [1 ]
Jin, Y. [1 ]
Selzler, K. J. [1 ]
Tepper, S. J. [3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Ctr Hosp Univ Nice, Nice, France
[3] Geisel Sch Med Dartmouth, Hanover, NH USA
来源：
CEPHALALGIA | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [31] Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results From a Long-term Open-Label Safety Study (Study 201)
    Hutchinson, S.
    Schim, J.
    Lipton, R. B.
    Croop, R.
    Stock, E. G.
    Thiry, A. C.
    Conway, C. M.
    Lovegren, M.
    Coric, V
    Jensen, C. M.
    HEADACHE, 2020, 60 : 122 - 123
  • [32] Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients - Patient-reported outcomes from multiple controlled and open-label extension studies
    Schiff, MH
    Yu, EB
    Weinblatt, ME
    Moreland, LW
    Genovese, MC
    White, B
    Singh, A
    Chon, Y
    Woolley, JM
    DRUGS & AGING, 2006, 23 (02) : 167 - 178
  • [33] Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
    Kudrow, David
    Hutchinson, Susan
    Pixton, Glenn C.
    Fullerton, Terence
    PAIN AND THERAPY, 2025, 14 (01) : 237 - 255
  • [34] Assessment of the Long-Term Safety and Efficancy of Erenumab During Open-Label Treatment of Patients With Chronic Migraine
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (15)
  • [35] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (04): : 653 - 661
  • [36] Rapid Responders to Frovatriptan in Acute Migraine Treatment: Results from a Long-Term, Open-Label Study
    Spierings, Egilius L. H.
    Keywood, Charlotte
    PAIN MEDICINE, 2009, 10 (04) : 633 - 638
  • [37] Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A)
    Duffin, K. Callis
    Bagel, J.
    Bukhalo, M.
    Clement, I. J.
    Choi, S. L.
    Zhao, F.
    Gill, A.
    Pangallo, B.
    Shuler, C.
    Mallbris, L.
    Jackson, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 107 - 113
  • [38] A Phase 3 Open-Label Trial of Low-Dose Solumatrix Diclofenac in Patients with Osteoarthritis Pain: Impact of Long-Term Administration on Patient-Reported Outcomes.
    Strand, Vibeke
    Gibofsky, Allan
    Hochberg, Marc
    Altman, Roy
    Cryer, Byron
    Kivitz, Alan
    Imasogie, Olaolu
    Young, Clarence
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S104 - S104
  • [39] An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients
    Ersoy, Mehmet A.
    Noyan, Aysin M.
    Elbi, Hayriye
    CLINICAL DRUG INVESTIGATION, 2008, 28 (02) : 113 - 120
  • [40] Long-term open-label study of pramipexole in patients with primary restless legs syndrome
    Inoue, Yuichi
    Kuroda, Kenji
    Hirata, Koichi
    Uchimura, Naohisa
    Kagimura, Tatsuo
    Shimizu, Tetsuo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 294 (1-2) : 62 - 66
12345